Vaxigrip Junior Injektionsvätska, suspension

Valsts: Zviedrija

Valoda: zviedru

Klimata pārmaiņas: Läkemedelsverket (Medical Products Agency)

Aktīvā sastāvdaļa:

influensavirus A/California/7/2009 (H1N1)pdm09-deriverad stam (NYMC X-179A), spjälkat virus, inaktiverat; influensavirus A/Texas/50/2012 (H3N2)-deriverad stam (NYMC X-223A), spjälkat virus, inaktiverat; influensavirus B/Massachusetts/2/2012, spjälkat virus, inaktiverat

Pieejams no:

Sanofi Pasteur MSD

ATĶ kods:

J07BB02

SNN (starptautisko nepatentēto nosaukumu):

the influenza virus A/California/7/2009 (H1N1)pdm09-derived strain (NYMC X-179A), spjälkat virus, inactivated; influenza virus, A/Texas/50/2012 (H3N2)-derived strain (NYMC X-223A), spjälkat virus, inactivated; influenza virus B/Massachusetts/2/2012, spjälkat virus, inactivated

Zāļu forma:

Injektionsvätska, suspension

Kompozīcija:

influensavirus A/California/7/2009 (H1N1)pdm09-deriverad stam (NYMC X-179A), spjälkat virus, inaktiverat 7,5 mikrog Aktiv substans; influensavirus A/Texas/50/2012 (H3N2)-deriverad stam (NYMC X-223A), spjälkat virus, inaktiverat 7,5 mikrog Aktiv substans; influensavirus B/Massachusetts/2/2012, spjälkat virus, inaktiverat 7,5 mikrog Aktiv substans

Receptes veids:

Receptbelagt

Ārstniecības joma:

spjälkat virus eller ytantigen

Autorizācija statuss:

Avregistrerad

Autorizācija datums:

1999-05-21